Food and Drug Administration
November 6, 2005
Slides
CDER Drug Safety Update, Steven Galson, MD, MPH (HTM) (PPT)
CDER Drug Safety Oversight Board, Douglas Throckmorton, MD (HTM) (PPT)
Update on FDA Cross-Cutting Initiatives, Dr. Janet Woodcock (HTM) (PPT)
FDA's New Bioresearch Monitoring Initiaive, Dr. Janet Woodcock (HTM) (PPT)
External Peer Review of the FDA Office of Regulatory Affairs Pesticide Program (HTM) (PPT)
Science Prioritization Process -- How it Works and What are Some Results?, Larry Kessler, ScD (HTM) (PPT)
National Antimicrobial Resistance Monitoring System (NARMS), Linda Youngman, MS, PhD (PPT) (PDF)
Open Public Hearing
The Reduction of Animal Use in medical Product Development, Sadhana Dhruvakumar, People for the Ethical Treatment of Animals (PDF)
Presentation on Behalf of the Union of Concerned Scientists and Kee Antibiotics Working, Susan Prolman, Esq. (PDF)